Akebia therapeutics announces corporate updates and 2026 pipeline outlook
Source: SeekingAlpha
2026-01-12 10:46:10 ET
More on Akebia
- Akebia Therapeutics, Inc. (AKBA) Q3 2025 Earnings Call Transcript
- Akebia Therapeutics: Dialysis-Only Path Puts VOCAL/Protocol Wins At The Core
- Akebia signals 7x increase in patient access for Vafseo entering 2026 amid operational focus
- Akebia GAAP EPS of $0.00 beats by $0.01, revenue of $58.78M beats by $2.36M
- Seeking Alpha’s Quant Rating on Akebia
Read the full article on Seeking Alpha
For further details see:
Akebia therapeutics announces corporate updates and 2026 pipeline outlook
Unisource Corp.
NASDAQ: USRC
USRC Trading
0.0% G/L:
$0.0003 Last:
100 Volume:
$0.0003 Open:
